Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2005; 11(24): 3772-3777
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3772
Figure 1
Figure 1 Injection of anti-CD25 mAb results in selective loss of CD25+ cells. Mice (six mice per group) were injected with 500 μg of anti-CD25 mAb (PC61) and analyzed by flow cytometry at the indicated days after treatment. Representative responses of PBMCs from one mouse are shown (A). Data are expressed as a percentage of CD25+CD4+ cells in the CD4+ cell population in peripheral blood. Three experiments were performed with similar results (B). Data are shown as the mean±SD of six mice tested individually n = 6.